Allakos Inc (ALLK)
1.45
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.45
0.00 (0.00%)
After-Hours: 20:00
Allakos SG&A Expense (Quarterly): 10.90M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 10.90M |
December 31, 2023 | 11.18M |
September 30, 2023 | 11.46M |
June 30, 2023 | 10.54M |
March 31, 2023 | 11.97M |
December 31, 2022 | 10.83M |
September 30, 2022 | 13.01M |
June 30, 2022 | 14.67M |
March 31, 2022 | 18.84M |
December 31, 2021 | 23.21M |
September 30, 2021 | 19.06M |
June 30, 2021 | 16.21M |
March 31, 2021 | 16.67M |
December 31, 2020 | 15.82M |
September 30, 2020 | 12.06M |
Date | Value |
---|---|
June 30, 2020 | 12.06M |
March 31, 2020 | 11.59M |
December 31, 2019 | 10.27M |
September 30, 2019 | 7.517M |
June 30, 2019 | 5.946M |
March 31, 2019 | 5.829M |
December 31, 2018 | 4.482M |
September 30, 2018 | 3.269M |
June 30, 2018 | 2.375M |
March 31, 2018 | 2.308M |
December 31, 2017 | 1.395M |
September 30, 2017 | 0.90M |
June 30, 2017 | 0.84M |
March 31, 2017 | 0.613M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
5.946M
Minimum
Jun 2019
23.21M
Maximum
Dec 2021
13.19M
Average
12.01M
Median
SG&A Expense (Quarterly) Benchmarks
Tonix Pharmaceuticals Holding Corp | 9.31M |
RAPT Therapeutics Inc | 7.737M |
NovaBay Pharmaceuticals Inc | 3.346M |
Palatin Technologies Inc | 2.033M |
iBio Inc | 2.961M |